Aditya Birla Sun Life Pharma & Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Aditya Birla Sun Life Pharma & Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹1000

AUM (Fund size)

901 Cr

Lock In Period

N/A

Expense Ratio

2.3

Exit Load

For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.

Benchmark

BSE Healthcare Total Return

Summary

Aditya Birla Sun Life Pharma & Healthcare Fund Growth NAV is ₹33.49 as of 16 May, 2026. Aditya Birla Sun Life Pharma & Healthcare Fund Growth has delivered 90.53% returns since its launch. The minimum SIP investment amount in Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹100. The AUM of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹901 Cr. The expense ratio of the fund is 2.3%, and its benchmark is BSE Healthcare Total Return. The current exit load of the fund is For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.. In the last 1M months, Aditya Birla Sun Life Pharma & Healthcare Fund Growth has delivered 7.51% returns.

Aditya Birla Sun Life Pharma & Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M7.510.669.72
6M4.831.608.52
1Y11.385.1115.26
3Y23.9714.01113.97

Portfolio Analysis

  • Equity: 97.62%
  • Debt: 2.35%
  • Others
As on: 2026-03-31
View allocation % by

1. Sun Pharmaceutical Industries Limited13.42%
2. Torrent Pharmaceuticals Limited5.03%
3. J.B. Chemicals & Pharmaceuticals Limited4.99%
4. Aurobindo Pharma Limited4.42%
5. Ajanta Pharmaceuticals Limited4.22%
6. Lupin Limited4.21%
7. IPCA Laboratories Limited4.11%
8. Abbott India Limited3.90%
9. Emcure Pharmaceuticals Ltd3.30%
10. Cipla Limited3.24%
11. Mankind Pharma Ltd2.93%
12. Shilpa Medicare Ltd2.26%
13. Alkem Laboratories Limited2.16%
14. CORONA Remedies Ltd2.12%
15. SAI Life Sciences Ltd2.09%
16. Procter & Gamble Health Limited1.97%
17. Divi's Laboratories Limited1.80%
18. Dr. Reddys Laboratories Limited1.45%
19. Pfizer Limited1.40%
20. ALEMBIC PHARMACEUTICALS LIMITED1.24%
21. Biocon Limited1.14%
22. Jubilant Pharmova Ltd1.11%
23. ANTHEM BIOSCIENCES LIMITED1.08%
24. Gland Pharma Limited0.99%
25. Piramal Pharma Ltd0.92%
26. GlaxoSmithKline Pharmaceuticals Limited0.87%

1. Apollo Hospitals Enterprise Limited7.34%
2. Fortis Healthcare Limited3.49%
3. Jupiter Life Line Hospitals Ltd1.96%
4. Thyrocare Technologies Limited1.44%
5. METROPOLIS HEALTHCARE LIMITED1.36%
6. Suraksha Diagnostic Ltd0.89%
7. Vijaya Diagnostic Centre Limited0.78%
8. Max Healthcare Institute Limited0.78%

1. SANOFI CONSUMER HEALTHCARE1.58%

About Fund Aditya Birla Sun Life Pharma & Healthcare Fund Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Growth managed by Aditya Birla Sun Life Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹901 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.3. Under the expert guidance of Dhaval Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Dhaval Shah

Mr. Dhaval Shah holds B.Com, CFA, MMS - Finance (Post graduation). He has worked with Morgan Stanley Investment Management, Reliance Capital Asset Management Ltd. and Edelweiss Securities.

Peer Comparison

Fund Name1Y3Y
This FundNippon India Pharma Fund Growth8.265487.0192
This FundTata India Pharma & HealthCare Fund Growth6.43887.1141
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth11.379190.5288
This FundUTI Healthcare Fund Growth11.4673101.0945
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth9.8076108.6846

Aditya Birla Sun Life Pharma & Healthcare Fund Growth FAQs

Aditya Birla Sun Life Pharma & Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is 2.3. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Aditya Birla Sun Life Pharma & Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 7.51%
  • 6 Months : 4.83%
  • 1 Year : 11.38%
  • 3 Years : 23.97%
Returns of Aditya Birla Sun Life Pharma & Healthcare Fund Growth are updated daily based on NAV of ₹ 33.49 as on May 14,2026. Since inception, the return has been 90.53%.

You can invest in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹901 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.